|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operations | |||||
| Depreciation and amortization | |||||
| Stock option expense | |||||
| Benefit for deferred income taxes | |||||
| Noncash portion of long-term incentive compensation | |||||
| Litigation settlements | |||||
| Noncash directors' compensation | |||||
| Amortization of debt issuance costs | |||||
| Changes in operating assets and liabilities: | |||||
| (Increase)/decrease in accounts receivable | |||||
| Decrease/(increase) in inventories | |||||
| (Increase)/decrease in prepaid expenses | |||||
| Decrease in accounts payable and other current liabilities | |||||
| Change in current income taxes | |||||
| Net change in lease assets and liabilities | |||||
| Decrease/(increase) in other assets | |||||
| Increase in other liabilities | |||||
| Other sources | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds from sale of fixed assets | |||||
| Business combinations, net of cash acquired | |||||
| Other uses | |||||
| Net cash used by investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Purchases of treasury stock | |||||
| Dividends paid | |||||
| Proceeds from exercise of stock options | |||||
| Change in cash overdraft payable | |||||
| Capital stock surrendered to pay taxes on stock-based compensation | |||||
| Payments on other long-term debt | |||||
| Other sources/(uses) | |||||
| Net cash used by financing activities | |||||
| (Decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...